| Product NDC: | 10802-1202 |
| Proprietary Name: | Ergomar |
| Non Proprietary Name: | Ergotamine Tartrate |
| Active Ingredient(s): | 2 mg/1 & nbsp; Ergotamine Tartrate |
| Administration Route(s): | SUBLINGUAL |
| Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 10802-1202 |
| Labeler Name: | Rosedale Therapeutics |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA087693 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120831 |
| Package NDC: | 10802-1202-3 |
| Package Description: | 3 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, UNIT-DOSE (10802-1202-3) |
| NDC Code | 10802-1202-3 |
| Proprietary Name | Ergomar |
| Package Description | 3 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, UNIT-DOSE (10802-1202-3) |
| Product NDC | 10802-1202 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ergotamine Tartrate |
| Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
| Route Name | SUBLINGUAL |
| Start Marketing Date | 20120831 |
| Marketing Category Name | ANDA |
| Labeler Name | Rosedale Therapeutics |
| Substance Name | ERGOTAMINE TARTRATE |
| Strength Number | 2 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Ergotamine Derivative [EPC],Ergotamines [Chemical/Ingredient] |